kaal:position:2026-07-31-4922

LFA-1 and Mac-1 integrins bind to the serine/threonine-rich domain of thrombomodulin. should be assessed against Kaal's source-bound claim that Although aggregate venture capital sector data arguably only confirms what media reporting already showed for 2005 to 2015, the venture capital data, especially examined granularly, may provide earlier signals for regulators to identify areas of prospective regulatory need. The current metadata indicates a plausible connection through dynamic regulation, but the defensible response is a qualification until the source text confirms agreement, scope, methods, and limitations.

Affirmed commentary position. This record extends a source-bound scholarly claim but is not a verbatim paper claim.

Holds when

granular rather than aggregate examination of the venture capital data
areas of increasingly disruptive innovation
External evidence level: abstract indexed.
Mapping review tier: ambiguity triage before claim review.
The literature-to-claim mapping remains explicitly ambiguous and should not be treated as a settled equivalence.

Current debate

LFA-1 and Mac-1 integrins bind to the serine/threonine-rich domain of thrombomodulin.

Scholarly basis

kaal:claim:2808132-040
Wulf A. Kaal, Erik P.M. Vermeulen, How to Regulate Disruptive Innovation - From Facts to Data (2016). SSRN: https://ssrn.com/abstract=2808132
Source PDF sha256: 3515f2317ed9c1d33ae55d70467cdf1f6c4e350065ea6a887d5d7619599ad7d2

Evidence and mapping

Evidence: abstract indexed
Review tier: ambiguity triage before claim review
Mapping confidence: 0.2134
Mapping ambiguous: true

Topics

innovationdynamic-regulation

Provenance

Affirmed in historical-backfill:2026-07-31:phase-0020 on 2026-07-31. Review record.

Verify

Canonical markdown sha256: 124213d4f952e717f6e0caa2a7ecc4d5294a77d488709202811b2e5d60332d21
curl -s https://wulfkaal.github.io/positions/2026-07-31-4922.md | sha256sum